Depletion of Plasma Factor XIII Prevents Disseminated Intravascular Coagulation-induced Organ Damage

Summary

The impact of clot stability affecting the vasculopathy and tissue necrosis in Shwartzman reaction was investigated using plasma Factor XIII A₂-depleted rabbit (FXIII-DR). Plasma Factor XIIIA₂ (FXIIIA₂) was depleted by infusion of the mono-specific goat anti-rabbit FXIIIA₂ IgG. Generalized Shwartzman reaction (GSR) was induced by priming and challenged by i.v. injection of LPS and local Shwartzman reaction (LSR) was primed by intradermal injection of LPS and challenged by i.v. injection of LPS. Histological examination of the GSR animals showed, extensive thrombi accumulation in renal tubules and bilateral cortical necrosis of kidney in 8 out of 10 rabbits but none in the FXIIIDR. Fibrinogen levels were elevated to 3~4 fold at 24 h and lowered at 48 h whereas a steady rise was seen in the FXIII-DR. FDP levels in GSR animals were significantly elevated at 24 h and further increased at 48 h but only slightly elevated in the FXIII-DR. Examination of the LSR tissues after 48 h showed an acute onset of progressive cutaneous vascular thrombosis, purpura, and secondary hemorrhagic necrosis whereas neither fibrin deposit nor necrosis of tissue were detected in FXIII-DR despite of an early edema formation. Fibrinogen levels were also increased two fold at 24 h but returned to basal levels at 48 h in control LSR animals but not affected at all in FXIII-DR. These results suggest that during the severe inflammatory conditions such as sepsis, the fibrinolytic system is functionally sufficient to dissipate the pathogenic accumulation of disseminated intravascular clots and exudated fibrin clots if those clots were prevented from getting cross-linked in plasma.

Keywords

Plasma - factor XIII - GSR - LPS

• References

• 1 Levi M, de Jonge E, van der Poll T, ten Cate H. Disseminated intravascular coagulation. Thromb Haemost 1999; 82: 695-705.
• 2 Ferhniger TA, Yu H, Cooper MA, Suzuki K, Shah MH, Caligiuri MA. Cutting edge IL-15 costimulates the generalized Shwartzman reaction and innate immune TNF-gamma production in vivo . J Immunol 2000; 1643-7.
• 3 Koide N, Narita K, Kato Y, Sugiyama T, Charkravortty D, Morikawa A, Yoshida T, Yokochi T. Expression of Fas and Fas ligand on mouse renal tubular epithelial cells in the generalized Shwartzman reaction and its relationship to apoptosis. Infect Immun 1999; 67: 4112-8.
• 4 Darmstadt GL. Acute infectious purpura fulminans: pathogenesis and medical management. Pediatr Dermatol 1998; 15: 169-83.
• 5 ten Cate H, Timmerman JJ, Levi M. The pathophysiology of disseminated intravascular coagulation. Thromb Haemost 1999; 82: 713-7.
• 6 Senaldi G, Piguet PF. Mortality and platelet depletion occur independently of fibrinogen consumption in murine models of tumor necrosis factor-mediated systemic inflammatory responses. Cytokine 1998; 10: 382-9.
• 7 Uchino R, Cardinali M, Chung SI. Regulation of extravascular fibrinolysis by Factor XIII. Fibrinolysis 1991; 5: 93-8.
• 8 Folk JE, Chung SI. Transglutaminases. Methods in Enzymology 1985; 256: 358-75.
• 9 Ouchterlony O. Diffusion-in-gel method for immunological analysis. Progr Allergy 1958; 5: 1-78.
• 10 Karpatkin S, Ferziger R, Dorfman D. Crossed immunoelectrophoresis of human platelet membranes. Effect of charge on association and dissociation of the glycoprotein GPIIb-GPIIIa membrane complex. J Biol Chem 1986; 261: 14266-72.
• 11 Merskey C, Larelzari P, Johnson AJ. A rapid, simple, sensitive method for measuring fibrinolytic split products in human serum. Proc Soc Exp Biol Med 1969; 131: 871-5.
• 12 Deutsch DG, Mertz ET. Plasminogen: purification from human plasma by affinity chromatography. Science 1970; 170: 1095-6.
• 13 Cardinali M, Uchino R, Chung SI. Interaction of fibrinogen with murine melanoma cells: Covalent association with cell membranes and protection against recognition by lymphokine-activated killer cells. Cancer Res 1990; 50: 8010-6.
• 14 Bolton AE, Hunter WM. The labelling of proteins to high specific radioactivities by conjugation to a ¹²⁵I-containing acylating agent. Biochem J 1973; 133: 529-39.
• 15 Friedman GD, Klatsky AL, Siegelaub AB. The leukocyte count as a predictor of myocardial infarction. N Engl J Med 1974; 290: 1275-8.
• 16 Bull BS, Scheiderman MA, Brecher G. Platelet counts with the Coulter count. Am J Clin Pathol 1965; 44: 344-7.
• 17 Paramo JA, Alfaro MJ, Rccha E. Postoperative change in the plasmatic levels of tissue type plasminogen activator and its fast-acting inhibitor-relationship to deep vein thrombosis and influence of prophylaxis. Thromb Haemost 1985; 54: 713-6.
• 18 Dukert F. Documentation of the plasma factor XIII deficiency in man. Ann N, Y Acd Sci 1972; 202: 190-9.
• 19 Biemond BJ, Levi M, ten Cate H, van der Poll T, Buller HR, Hack CE, ten Cate JW. Plasminogen activator and plasminogen activator inhibitor 1 release during experimental endotoxemia in chimpanzees: effects of interventions in the cytokine and coagulation cascades. Clin Sci (Colch) 1995; 88: 587-94.
• 20 Crutchley DJ, Conanan LB. Endotoxin induction of an inhibitor of plasminogen activator in bovine pulmonary artery endothelial cells. J Biol Chem 1985; 261: 154-9.
• 21 Suffredini AF, Harpel PC, Parrillo JE. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med 1989; 320: 1165-72.
• 22 Hamaguci M, Morishita Y, Takahashi I, Ogura M, Yakamatsu J, Saito H. FDP D-dimer induces the secretion of interleukin-1, Urokinase-type plasminogen activator, and plasminogen activator inhibitor-2 in a human promonocytic leukemia cell line. Blood 1991; 77: 94-100.
• 23 Olman MA, Hagood JS, Simmons WL, Fuller GM, Vinson C, White KE. Fibrin fragment induction of plasminogen activator inhibitor transcription is mediated by activator protein-1 through a highly conserved element. Blood 1999; 94: 2029-38.
• 24 Chung SI, Lee SY, Uchino R, Carmassi F. Factors that control extra-vascular fibrinolysis. Seminars in Thromb Haemost 1996; 22: 479-88.